Skip to content

Clinical trials

Phase 4 Diabetes Mellitus, Type 2 trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 4 Country / region: Brazil Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20071
20082
20091
20109
20112
20123
20133
20142
20152
20162
20171
20181
20191
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi10
University of Sao Paulo General Hospital5
Eli Lilly and Company4
Novo Nordisk A/S3
University of Campinas, Brazil3
Centro de Diabetes Curitiba Ltda2
University of Sao Paulo2
AstraZeneca1
Boehringer Ingelheim1
Dr. José Fernando Vilela-Martin MD PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 237
Diabetes Mellitus10
Coronary Artery Disease3
Hypertension3
Acute Kidney Injury2
Insulin Resistance2
Albuminuria1
Arrhythmias, Cardiac1
Bone Diseases, Metabolic1
Cardiomegaly1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.